Anti-EGFR immunoliposomes for cabazitaxel delivery: From formulation development to in vivo evaluation in prostate cancer xenograft model.
Carolina Cruz de Sousa A, da Silva Santos E, da Silva Moreira T, Gabriela Araújo Mendes M, Rodrigues Arruda B, de Jesus Guimarães C, de Brito Vieira Neto J, Santiago de Oliveira Y, Pedro Ayala A, Rodrigues da Costa MD, Lima Sampaio T, Paula Negreiros Nunes Alves A, Pessoa C, Petrilli R, Eloy JO.
Carolina Cruz de Sousa A, et al. Among authors: petrilli r.
Int J Pharm. 2024 Aug 15;661:124439. doi: 10.1016/j.ijpharm.2024.124439. Epub 2024 Jul 6.
Int J Pharm. 2024.
PMID: 38972520